Search Results
Jan 21, 2026, 09:23 ET SONOMOTION ANNOUNCES FDA CLEARANCE FOR ITS BREAK WAVE™ LITHOTRIPSY DEVICE FOR TREATMENT OF KIDNEY STONES
anesthesia-free and non-invasive treatment pathway: Break Wave fragments the stone, while Stone Clear helps clear the kidney of residual fragments post-lithotripsy. Stone Clear was granted FDA 510(k) de novo clearance in October 2024."Receiving FDA clearance is a pivotal milestone for our company
More news about: SonoMotion, Inc.
Jan 21, 2026, 09:08 ET January Issue of Journal of Cardiac Failure-Intersections Examines How Innovation, Advanced Mechanical Support, and Prescribing Design Are Reshaping Heart Failure Care
de novo atrial fibrillation during peripheral veno-arterial ECMO as a marker of significantly higher post-decannulation mortality, sharpening clinical insight at a vulnerable inflection point in advanced heart failure care.Another study turns to prescribing
More news about: Heart Failure Society of America
Jan 21, 2026, 09:00 ET Benepass Raises $40M Series B to Help Employers Redesign Benefits for Rising Healthcare Costs
Portage Ventures and Threshold Ventures. The funding will support Benepass' efforts to expand into larger, more complex employers with their pre- and post-tax benefit offerings. The platform will be positioned to support more specialized and cost-sensitive programs.
More news about: Benepass
Jan 21, 2026, 09:00 ET Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Patients Receiving a Liver Transplant
However, OLT patients require life-long immunosuppression, often associated with complex dosing regimens and comorbid toxicities. Despite advancements in post-transplant clinical care, complications of immunosuppression and allograft rejection may negatively impact graft and patient survival. Therefore, a
More news about: Veloxis Pharmaceuticals
Jan 21, 2026, 08:59 ET Technician Find Founder Chris Lawson Featured in 'Beyond the Bays' by Hunt Demarest, CPA/ABV
need to say in order to attract that person," Lawson explains in the spotlight. (Chapter 5, p. 45)This approach contrasts with the reactive, post-and-pray hiring tactics that leave many shop owners cycling through unqualified applicants while their bays sit empty.About the BookBeyond
More news about: Technician Find
Jan 21, 2026, 08:49 ET Like Minded Labs Launches Coresee: A Precision-Grade Virtual Conferencing Post-Production Workspace
preserved. While many remote collaboration tools are designed for casual screen sharing or one-off meetings, Coresee was built to support real post-production work. The platform enables creative teams to collaborate with high-resolution visual clarity, maintain context across sessions, and retain
More news about: Like Minded Labs
Jan 21, 2026, 08:42 ET VectorCare Launches SoFaaS™ (SMART on FHIR as a Service)
development or production include:Seamless transportation and mobility scheduling (Lyft integration)Home health and post-acute referralsDurable medical equipment (DME) orderingRemote patient monitoring data flowsCommunity-based social determinants
More news about: VectorCare
Jan 21, 2026, 08:41 ET FRIDAY DEADLINE: Berger Montague Advises Stubhub Holdings, Inc. (NYSE: STUB) Investors to Contact the Firm Before January 23, 2026
complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law,
More news about: Berger Montague
Jan 21, 2026, 08:31 ET 2026 NYC Hospitality Forecast: "Neuro-Gastronomy" and Ingredient Purity Replace Old Luxury in High-End Dining
Drawing on an audit of over 50 tasting menus from leading New York hospitality groups and consumer sentiment data, the study confirms a clear trend: The post-2025 consumer is no longer impressed by legacy ingredients like heavy cream or foie gras. Instead, they demand culinary engineering that supports longevity
More news about: Culinary Architect Studio
Jan 21, 2026, 08:30 ET CereVasc Completes Enrollment of ETCHES Study of the eShunt® System for the Treatment of Communicating Hydrocephalus
feasibility, safety and performance of the eShunt System in adults who develop communicating hydrocephalus, due to increased intracranial pressure, following post-aneurysmal subarachnoid hemorrhage (SAH).All procedures in the trial were performed by neurovascular surgeon and Principal Investigator Pedro
More news about: CereVasc
Jan 21, 2026, 08:25 ET Mars Honored by Glassdoor as One of the Best Places to Work in the U.S.
reviews, salaries and more at millions of employers, and to join communities to engage in candid workplace conversations. Companies use Glassdoor to post jobs and attract talent through employer branding and employee insights products. Glassdoor is part of Indeed, a subsidiary of Recruit Holdings, a
More news about: Mars, Incorporated
Jan 21, 2026, 08:01 ET Findhelp and MiResource Are Partnering to Improve Behavioral and Mental Health Care Access
our recent SimplePractice announcement and reflects our broader strategy to bring behavioral health into the same coordinated workflows as social and post-acute care."Adding Infrastructure to Improve Access with MiResourceBehavioral health navigation has been fragmented for decades.
More news about: Findhelp
Jan 21, 2026, 08:00 ET ECB STAR Group Launches U.S. Pre-Deal Practice
at Alvarez & Marsal. "Sponsors are increasingly looking to enhance traditional diligence to understand how value will actually be created post-close. By linking pre-deal insights directly to execution, ECB can help investors make better decisions and accelerate impact from day one."Pre-Deal
More news about: ECB STAR Group
Jan 21, 2026, 08:00 ET Samson Partners Expands Platform With Launch of Samson Partners Capital and Key Leadership Appointments
operations boast long-standing relationships with more than 200 private equity firms and bring an operator's perspective to investor fit, deal structure and post-close success."Owners and operators consistently told us they didn't want to hand their business off between disconnected advisors," said Seth
More news about: Samson Partners Capital
Jan 21, 2026, 07:30 ET BTQ Technologies and ITRI Partner to Validate QCIM Quantum Secure Chip in Silicon
cost of post-quantum cryptography by evaluating the feasibility, performance, and energy efficiency of PQC workloads using compute-in-memory approaches."BTQ previously announced a separate collaboration with ICTK, with ICTK focused on implementation of a complete, commercially deployable post-quantum
More news about: BTQ Technologies Corp.
Jan 21, 2026, 07:30 ET Keenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition
changes to applicable tax laws or the impact of disputes with governmental tax authorities; the impact of Irish laws; the comparability of the Company's post-emergence financial results and the projections filed with the U.S. Bankruptcy Court for the District of Delaware and the lack of comparability of the
More news about: Keenova Therapeutics
Jan 21, 2026, 07:01 ET Southwest Florida Commercial Real Estate Market Enters a "Back to Reality" Phase Heading Into 2026
pulled back over the past year, choosing caution over risk amid ongoing economic uncertainty.Underwriting Discipline ReturnsThe post-COVID environment saw transactions underwritten on aggressive assumptions, often minimizing vacancy, tenant risk, capital expenditures, and leasing
More news about: Mayhugh Commercial Advisors
Jan 21, 2026, 07:00 ET The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes ("T1D") Therapies
regulatory T cells—pathways critical to restoring immune tolerance in T1D. Dr. Foy holds a Ph.D. in immunology from the University of Iowa and completed her post-doctoral fellowship in immunology at Dartmouth Medical School. She has also held senior R&D roles at Corixa and GlaxoSmithKline, in addition to
More news about: The T1D Fund
Jan 21, 2026, 06:10 ET Brand Engagement Network Secures $2.050 Million AI Licensing Partnership in Africa
students are at alarming levels globally. In South Africa, prevalence rates for anxiety disorders reach up to 37.1% among students1, with post-traumatic stress disorder (PTSD) affecting 21-24.5%2, and overall perceived stress impacting 64.7% of university students across Africa3.
More news about: Brand Engagement Network, Inc. (BEN)
Jan 21, 2026, 05:47 ET Matthew DelMauro, MD Observes Rise in Plastic Surgery at his NYC Practice Following GLP-1-Related Weight Loss
with how healthy and confident they feel on the inside."As interest in GLP-1 medications continues to grow, Dr. DelMauro expects post–weight loss plastic surgery to remain an important and evolving part of patient care, bridging the gap between medical weight management and aesthetic
More news about: Matthew DelMauro, MD
Jan 21, 2026, 02:20 ET Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
operations and expanded project execution across the company's manufacturing network. [Consolidated earnings for CDMO business, post spin-off basis, KRW billion]
More news about: Samsung Biologics
Jan 21, 2026, 02:00 ET Sigrid Enters Exclusive Global Licensing and Research Collaboration to Commercialize SiPore® in Consumer Oral Health
clinically proven products — Carb Fence, designed to reduce appetite and cravings while supporting fat loss, lean muscle preservation, and post-meal blood sugar control, and Glucose Stabiliser, a dietary supplement designed to help regulate blood sugar after meals — Sigrid today
More news about: Sigrid Therapeutics
Jan 20, 2026, 18:34 ET Caracal Products & Services Congratulates Graduates of Caracal Academy
future business leaders. Since the programs' inception, Caracal has granted $81,500 in scholarships to high school seniors and students enrolled in post-secondary programs. To learn more, visit
More news about: Caracal Products & Services
Jan 20, 2026, 17:15 ET Bridge to Life™ obtient l'autorisation de novo de la FDA pour le système de perfusion hypothermique et oxygénée VitaSmart™ (HOPE), la toute première autorisation américaine de perfusion en machine froide pour la préservation des greffes de foie
réduction du risque de réexposition à l'ischémie froide statique. Ces facteurs ont un impact direct sur la stabilité peropératoire et les résultats post-transplantation.Preuves cliniques à l'appui de l'autorisation de novoL'autorisation de la FDA s'appuie sur les données de l'essai
More news about: Bridge to Life, Ltd.
Jan 20, 2026, 16:35 ET Energy Fuels to acquire Australian Strategic Materials to create new "mine-to-metal & alloy" rare-earth champion
ASM share2. The transaction is expected to be accretive on NAVPS with significant value creation opportunity from margin uplift.Post-closing, ASM shareholders, as a group, would own approximately 5.8% of Energy Fuels' outstanding shares.ASM's Board has unanimously recommended that
More news about: Energy Fuels Inc.